Biogen ( BIIB )
How has the company changed?
Name Type Last Updated
How Did Biogen [BIIB] Fare in 2018 and What Can We Expect In 2019? Annual 2019-06-02


Name Type Last Updated
Cost And Expenses: Amortization Of Acquired Intangible Assets Annual 2019-01-23
Cost And Expenses: Cost Of Sales Excluding Amortization Of Acquired Intangible Assets Annual 2019-01-23
Revenues: Other Annual 2019-01-23
Revenues: Product Net Annual 2019-01-23
Revenues: Total Revenues From Anti-cd20 Therapeutic Programs Annual 2019-02-09


How does it make money?
Name Type Last Updated
What Are The Key Drivers Of Biogen's Expenses? Annual 2019-10-04


Income Statement Data: Historicals & Forecasts
Name Type Last Updated
Other Revenue: Revenues 2014-2020 Annual 2019-07-08
Revenues From Anti-cd20 Therapeutic Programs: Revenues 2014-2020 Annual 2019-07-08
Product Net: Revenues 2014-2020 Annual 2019-07-08
Cost And Expenses: Acquired In-process Research And Development 2015-2020 Annual 2019-07-08
Revenues 2014-2020 Annual 2019-07-08
Cost And Expenses: Cost Of Goods And Services Sold 2014-2020 Annual 2019-07-08
Cost And Expenses: Research And Development 2014-2020 Annual 2019-07-08
Cost And Expenses: Selling General And Administrative 2014-2020 Annual 2019-07-08
Cost And Expenses: Amortization And Impairment Of Acquired Intangible Assets 2014-2020 Annual 2019-07-08
Nonoperating Income 2014-2020 Annual 2019-07-08
Net Income Attributable To Noncontrolling Interests Net Of Tax 2014-2020 Annual 2019-07-08
Net Income Attributable To Parent 2014-2020 Annual 2019-07-08
Net Income Growth 2015-2020 Annual 2019-07-08
Net Income Including Portion Attributable To Noncontrolling Interest 2014-2020 Annual 2019-07-08
Net Income Margin 2014-2020 Annual 2019-07-08
Earnings Before Taxes 2014-2020 Annual 2019-07-08
Cost And Expenses: Restructuring Charges 2014-2020 Annual 2019-07-08
Income Tax Expense 2014-2020 Annual 2019-07-08
Change in EPS 2015-2020 Annual 2019-07-08
Earnings Per Share: Basic 2014-2020 Annual 2019-07-08
Earnings Per Share: Diluted 2014-2020 Annual 2019-07-08
Cost And Expenses: Total Cost And Expenses 2014-2020 Annual 2019-07-08
Income From Operations 2014-2020 Annual 2019-07-08
Gain On Sale Of Rights 2014-2020 Annual 2019-07-08
EBIT % of Sales 2014-2020 Annual 2019-07-08
SG&A % of Sales 2014-2020 Annual 2019-07-08
EBT Growth 2015-2020 Annual 2019-07-08
Revenue Growth 2015-2020 Annual 2019-07-08
Tax Rate 2014-2020 Annual 2019-07-08
Change in EBT 2015-2020 Annual 2019-07-08
Change in Total Expense 2015-2020 Annual 2019-07-08
Cost And Expenses: Collaboration Profit Sharing 2014-2020 Annual 2019-07-08
Cost And Expenses: Loss On Fair Value Remeasurement Of Contingent Consideration 2014-2020 Annual 2019-07-08
Cost And Expenses: Tecfidera Litigation Settlement And License Charges 2014-2020 Annual 2019-07-08
Total Expense 2014-2020 Annual 2019-07-08
Weighted-average Shares Used In Calculating: Basic Earnings Per Share Attributable To Biogen Idec Inc. 2014-2020 Annual 2019-07-08
Weighted-average Shares Used In Calculating: Diluted Earnings Per Share Attributable To Biogen Idec Inc. 2014-2020 Annual 2019-07-08
Equity In Loss Of Investee Net Of Tax 2014-2020 Annual 2019-07-08